Anti-androgenic effects of combination finasteride plus flutamide in patients with prostatic carcinoma

British Journal of Urology

Volumn 78, Issue 6, 1996, Pages 907-910

  Fleshner, N B ^a,b   Fair, W R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Urology Service   (United States)

Author keywords

Drug therapy; Finasteride; Flutamide; Prostatic neoplasms; Quality of life

Indexed keywords

FINASTERIDE; FLUTAMIDE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; GASTROINTESTINAL TOXICITY; GYNECOMASTIA; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 0030434949     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1996.29918.x     Document Type: Article

References (11)

1. Stamey TA, McNeal JE. Adenocarcinoma of the prostate. In Walsh PC, Retik AB. Stamey TA. Vaughan Jr ED eds. Campbell's Urology. 6th edn. Philadelphia: Saunders. 1992: 1159-221
2. Fleshner NE, Trachtenberg J. Treatment of advanced prostate cancer with the combination of flnasteride plus flutamide: early results. Eur Urol 1993; 23: 106-12
3. Karling P, Hammar M, Varenhorst E. Prevalence and duration of hot flushes after surgical or medical castration in men with prostatic carcinoma. J Urol 1994; 152: 1170-3
4. Crawford ED. Eisenberger MA, Mcleod DG et al. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Mud 1989; 321: 419-24
5. Tyrrell CJ, Altwein JE. Klippel F et al. for the International Prostate Cancer Study Group. A multicenter randomized trial comparing the luteinizing hormone-releasing hormone analog goserelin acetate alone and with (lutamide in the treatment of advanced prostate cancer, J Urol 1991; 146: 1321-6
6. Jones GW. Mettlin C, Murphy GP et al. Patterns of care for carcinoma of the prostate gland: results of a national survey of 1984 and 1990. J Am College Surg 1995: 180: 545-54
7. Stamey TA, Ferrari MK, Schmid HP. The value of serial prostate specific antigen determinations 5 years after radiotherapy: steeply increasing values 80% of patients. J Urol 1993: 150: 1856-9
8. Stoner E. Three-year safety and efficacy data on the use of flnasteride in the treatment of benign prostatic hyperplasia. Urology 1994: 43: 284-94
9. Fleshner NE, Trachtenberg J. Sequential androgen blockade: a biological study in the inhibition of prostate growth. J Urol 1992; 148: 1928-31
10. Fleshner NE. Trachtenberg J. Combination finasteride and (lutamide in advanced carcinoma of the prostate: effective therapy with minimal side effects. J Urol 1995: 154: 1642-6
11. Singer PA. Tasch ES, Stocking C. Rubin S, Siegler M, Weichselbaum P. Sex or survival: trade offs between quality and quantity of life. J Clin Oncol 1991; 9: 328-34